ClinicalTrials.gg
RecruitingNCT06382753Updated Apr 24, 2024

Impact of Periodontal Supportive Therapy in Patients With Gingivitis and Periodontitis

An observational study in Gingivitis and Periodontitis, sponsored by University of Catania. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-24.

Sponsored by University of Catania · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
150
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Gingivitis with a site in Italy — 9 open to participants now, 10 under way, 1 of them phase 3. Gingivitis · Italy.

Started
2024
with 3 others
Observational
4 of 32
3 open now
Registered
17th of 32
by date
Lead sponsor
3 of 32
University of Catania

Among the 32 studies in Gingivitis with a site in Italy, this one is one of 4 that started in 2024, is one of 4 observational ones, and was the 17th registered.

Gingivitis

636 studies on the registry are indexed under Gingivitis; 109 are open to participants now.

Browse Gingivitis studies →

Open to participants now

9 of the 32 studies in Gingivitis with a site in Italy are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 54 Gingivitis studies recruiting now, 16 (30%) set no upper age limit and 36 (67%) stop at 75 or younger; 11 take children under 18; 36 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Gingivitis with a site in Italy, or all of them as a file.
02

Study summary

The study evaluated the number of sessions of periodontal supportive treatment in patients with gingivitis in order to evaluate the risk of periodontitis development.

Read the detailed description

Patient with gingivitis were retrospectively evaluated. The number of periodontal supportive therapy were recorded other than gingivitis periodontal parameters over 5-years follow-up.

03

Conditions studied

  • Gingivitis
  • Periodontitis
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

150 patients with diagnosed gingivitis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Gingivitis

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of Periodontitis
  • Pregnancy
  • Systemic diseases
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
150 participants (estimated)
Patient registry
No

Interventions

  • OtherGingival inflammation

    Patients were scored for their status of gingival inflammation using Gingival Index and Bleeding on Probing Scores

06

What researchers measure

Primary outcomes

  1. Bleeding on Probing

    Evaluation of bleeding on probing reduction

    Time frame: 5-years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Study results

Supporting information: Study protocol

Time frame: 1-year

Access criteria: Pubmed

Data sharing details ↗ · pubmed.gov

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2024 (actual). Primary completion is estimated for Jun 2024, 2 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 20, 2024
First posted
Apr 24, 2024
StartActual
Apr 20, 2024
Primary completionEst.
Jun 30, 2024
CompletionEst.
Jun 30, 2024
Last update
Apr 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06382753
Lead sponsor
University of Catania
Responsible party
Gaetano Isola (Associate Professor, University of Catania) — Principal investigator
First posted
Apr 24, 2024
Start date
Apr 20, 2024
Primary completion
Jun 30, 2024 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Apr 24, 2024

Study contacts

Gaetano Isola
Contact
gaetano.isola@unict.it
0953785652
Rosalia Leonardi
Contact
rleonardi@unict.it
0953785652
Gaetano Isola
principal investigator · University of Catania

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion